Allurion Technologies (NYSE:ALUR) Now Covered by TD Cowen

TD Cowen started coverage on shares of Allurion Technologies (NYSE:ALUR) in a research report released on Wednesday, MarketBeat Ratings reports. The firm issued a buy rating and a $2.00 target price on the stock.

Other equities research analysts have also recently issued reports about the company. Roth Mkm assumed coverage on Allurion Technologies in a research note on Friday, September 6th. They issued a buy rating and a $2.00 price objective for the company. Roth Capital raised Allurion Technologies to a strong-buy rating in a research report on Friday, September 6th. Finally, Chardan Capital reduced their price target on shares of Allurion Technologies from $5.00 to $2.50 and set a buy rating on the stock in a research report on Thursday, August 22nd. Four equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of Buy and an average target price of $2.88.

Allurion Technologies Price Performance

Shares of ALUR stock opened at $0.71 on Wednesday. Allurion Technologies has a 1-year low of $0.55 and a 1-year high of $5.15. The firm has a market cap of $33.80 million, a PE ratio of -0.19 and a beta of -0.33. The company has a 50-day moving average of $0.68 and a two-hundred day moving average of $1.31.

Allurion Technologies (NYSE:ALUR) last issued its quarterly earnings data on Tuesday, August 13th. The company reported $0.01 EPS for the quarter. The company had revenue of $11.77 million during the quarter. Sell-side analysts anticipate that Allurion Technologies will post -0.3 EPS for the current fiscal year.

Hedge Funds Weigh In On Allurion Technologies

An institutional investor recently bought a new position in Allurion Technologies stock. CVI Holdings LLC purchased a new position in shares of Allurion Technologies Inc. (NYSE:ALUR) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 521,440 shares of the company’s stock, valued at approximately $520,000. Allurion Technologies makes up 0.5% of CVI Holdings LLC’s portfolio, making the stock its 28th largest position. CVI Holdings LLC owned about 1.09% of Allurion Technologies as of its most recent SEC filing. Institutional investors own 21.39% of the company’s stock.

About Allurion Technologies

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.